4-Bromo-3-methoxypyridine hydrochloride, 95.0%, 250mg

(3'-Fluoro-[1,1'-biphenyl]-3-yl)methanamine, 95%, 5g

[(anthracen-9-yl)methyl](prop-2-en-1-yl)amine, 95.0%, 10g

1-METHYL-6,7-DIMETHOXY-3,4-DIHYDROISOQUINOLINE, 97.0%, 250mg

Lanthanum(III) oxide, 99.99%, pa, 250 g, plastic packaging.

2-((2-Acetamido-6-oxo-1H-purin-9(6H)-yl)methoxy)ethyl acetate, 97.0%, 25g

6-Bromo-8-fluoronaphthalen-2-ol, 95.0%, 1g

1-Benzylidene-2-phenylhydrazine, 95.0%, 25g

Transition piece, 29/32, 60/46, 1 Piece

4-(4-Chlorophenyl)tetrahydro-2H-pyran-4-carboxylic acid, 95.0%, 1g

Methyl 2-(1-methylpiperidin-4-yl)acetate, 95.0%, 1g

4-Methylumbelliferyl-N-acetyl-β-D-galactosaminide, 100 mg

2,4,6-trimethylpyridine hexafluorophosphate, 98%, 10g